Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to evaluate the safety and effectiveness of the drugs
lenalidomide and ofatumumab in the treatment of chronic lymphocytic leukemia (CLL).